Equity Capital Markets
Aclaris Therapeutics, Inc.
10/26
Piper Sandler served as bookrunner for Aclaris Therapeutics on its October 2026 registered direct offering
© 2026 Piper Sandler Companies. Since 1895. All rights reserved.